Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
| IL10 / IL10RA mAb | Monospecific antibody | Infectious and parasitic diseases | Immunodeficiencies | PCC | Global |
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL0-H82Q3 | Human | Biotinylated Human IL-10 Protein, His,Avitag™ |  |
|
|
| FMBc003-02 | 0 | Anti-mouse IL-10 Antibody-coupled APC-beads-B03 | |||
| FABr017-B | Rat | Biotinylated Monoclonal Anti-Mouse IL-10 Antibody, Rat IgG2b (AS544) | |||
| GMP-L10H25 | Human | GMP Human IL-10 Protein |  |
|
|
| CRS-B005 | Human | ClinMax™ Human IL-10 ELISA Kit | |||
| IL0-C4248 | Cynomolgus | Cynomolgus IL-10 Protein, His Tag |  |
|
|
| IL0-H5219 | Human | Human IL-10 Protein, premium grade |  |
|
|
| CRS-A008 | Human | resDetect™ Human Interleukin-10 (IL-10) ELISA Kit (Residue Testing) | |||
| IL0-M4248 | Mouse | Mouse IL-10 Protein, His Tag |  |
|
|
| IL0-H4248 | Human | Human IL-10 Protein, His Tag |  |
|
|
GMP Human IL-10 Protein (Cat. No. GMP-L10H25) inhibits the secretion IL-6 by RAW264.7 cells. The specific activity of GMP Human IL-10 Protein is > 1.00 x 10^7 IU/mg, which is calibrated against WHO Reference Reagent Interleukin-10 (Human, rDNA derived) (NIBSC code: 93/722) (QC tested).
Human IL-10, premium grade (Cat. No. IL0-H5219) inhibits the secrection IL-6 by RAW264.7 cells. The specific activity of Human IL-10, premium grade is >1.00 x 10^7 IU/mg, which is calibrated against WHO Reference Reagent Interleukin-10 (Human, rDNA derived) (NIBSC code: 93/722) (QC tested).
Immobilized Cynomolgus IL-10 R alpha Protein, Fc Tag (Cat. No. ILR-C5256) at 5 μg/mL (100 μL/well) can bind Cynomolgus IL-10 Protein, His Tag (Cat. No. IL0-C4248) with a linear range of 0.01-0.313 μg/mL (QC tested).
The purity of Human IL-10, premium grade (Cat. No. IL0-H5219) is more than 90% and the molecular weight of this protein is around 35-45 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Mesenchymal stem cells therapy (Therapeutic Solutions International) | Phase 3 Clinical | Jadi Cell LLC | Coronavirus Disease 2019 (COVID-19) | Details | |
| WP-1303 (worgpharma) | ATX-MS-1467; ATX-MS-01; M-2736; WP-1303; MSC-2358825A | Phase 2 Clinical | Apitope Technology | Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Multiple Myeloma | Details |
| Faecalibacterium prausnitzii EXL01 (Exeliom) | EXL-01; EXL01 | Phase 2 Clinical | Exeliom Biosciences | Stomach Neoplasms; Clostridium Infections; Crohn Disease; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Bacterial Infections | Details |
| XT-150 | XT-101; XT-150; XT-101-R | Phase 2 Clinical | Xalud Therapeutics Inc | Multiple Sclerosis; Back Pain; Osteoarthritis, Knee; Neuralgia; Inflammation; Osteoarthritis, Spine; Arthralgia; Amyotrophic Lateral Sclerosis | Details |
| SFA-002 | SFA-002; SFA002 | Phase 1 Clinical | Arthritis, Rheumatoid; Plaque psoriasis | Details | |
| Anti-CD19 IL10 CAR-NK cell therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) | Phase 1 Clinical | Second Affiliated Hospital School Of Zhejiang University School Of Medicine | Lymphoma, B-Cell | Details | |
| KLS-2031 | KLS-2031 | Kolon Life Science. Inc | Details |
This web search service is supported by Google Inc.
A-Z
